10.3233/JAD-171124 60 NiuH.lvarez-lvarezI.Guilln-GrimaF.Aguinaga-OntosoI
Journal of the science of food and agriculture , 90 (2), 329337
Wegovy tablets and injections are FDA-approved in adults for: weight loss and weight management in adults with obesity or adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) reducing major cardiovascular event risks (such as heart attack, stroke, or death) in adults with established CV disease and either obesity or overweight Wegovy injection is also FDA-approved for: weight loss and weight management patients with obesity who are 12 years and older non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), this is an accelerated approval
Funding for the study was provided by National Institutes of Health grants R01AG077888, K02AG076883, R01DK114074, R01DK120518, K01DK132490, and K24AI144954
The 2026 Policy Breakdown and What to Do When You're Denied Does UnitedHealthcare Cover Weight Loss Injections
Ingredients, usage and warnings are in the detailed description below